Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram
Kaplan-Meier survival analyses of overall survival (A) and lung... | Download Scientific Diagram
Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis - The Lancet Oncology
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Real-world treatment and survival in early-stage NSCLC - Medical Conferences
Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer
Tumor Treating Fields Plus Standard of Care Improved Overall Survival Among Patients With Metastatic Non-Small Cell Lung Cancer on Vimeo
Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection | In Vivo
LIBTAYO® (cemiplimab-rwlc) Overall Survival Rate in Advanced NSCLC
File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg - Wikimedia Commons
Stereotactic ablative radiotherapy shows long-term benefit in operable early NSCLC
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer | NEJM
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer
Non-Small Cell Lung Cancer
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Stage Shift Improves Lung Cancer Survival: Real-World Evidence - Journal of Thoracic Oncology
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Overall survival curves of patients with lung cancer. The 5-year... | Download Scientific Diagram
